ID: ALA4516511

Max Phase: Preclinical

Molecular Formula: C20H18N4

Molecular Weight: 314.39

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  c1ccc(Cn2c(NCc3cccnc3)nc3ccccc32)cc1

Standard InChI:  InChI=1S/C20H18N4/c1-2-7-16(8-3-1)15-24-19-11-5-4-10-18(19)23-20(24)22-14-17-9-6-12-21-13-17/h1-13H,14-15H2,(H,22,23)

Standard InChI Key:  XPPUVSKPYRAVRF-UHFFFAOYSA-N

Associated Targets(non-human)

Short transient receptor potential channel 5 64 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 314.39Molecular Weight (Monoisotopic): 314.1531AlogP: 4.09#Rotatable Bonds: 5
Polar Surface Area: 42.74Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.44CX LogP: 3.87CX LogD: 3.83
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.60Np Likeness Score: -1.58

References

1. Sharma SH, Pablo JL, Montesinos MS, Greka A, Hopkins CR..  (2019)  Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903.,  29  (2): [PMID:30538066] [10.1016/j.bmcl.2018.12.007]

Source